3rd Apr 2009 17:16
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN
|
For Immediate Release |
03 April 2009 |
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Results of Equity Issue
MedicX Fund Limited, (LSE: MXF) (the "Company"), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, wishes to announce the results of its placing and offer for subscription of new ordinary shares (the "New Ordinary Shares").
The Company has raised £15 million through the placing and offer for subscription. 21,750,000 New Ordinary Shares will be issued at a price of 69 pence per share, of which 5,833,450 New Ordinary Shares will be issued pursuant to the offer for subscription and 15,916,550 New Ordinary Shares will be issued pursuant to the placing.
Application has been made for the New Ordinary Shares to be admitted to the Official List of the UK Listing Authority and to trading on the main market for listed securities of the London Stock Exchange plc. Dealings in the New Ordinary Shares are expected to commence on 08 April 2009.
David Staples, the Chairman of the Company, has subscribed under the offer for subscription for 20,000 New Ordinary Shares at a price of 69 pence per share.
-Ends-
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
MedicX Group +44 (0) 0808 2025461
Keith Maddin, Chairman
Mike Adams, Managing Director
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland/Mary-Jane Johnson/Miranda Higham
Collins Stewart Europe Limited
Robbie Robertson/Andrew Zychowski/Helen Goldsmith +44 (0) 20 7523 8000
Important Information
This announcement does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, any securities of the Company to any person in any jurisdiction to whom or in which such offer or solicitation is unlawful and, in particular, is not for release, publication or distribution in or into the United States, Australia, Canada or Japan. The Offer for Subscription and the Placing of the New Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the New Ordinary Shares may not be offered or sold in Australia, Canada, Japan or the United States.
The contents of this announcement have been prepared by and are the sole responsibility of the Company. Collins Stewart Europe Limited ("Collins Stewart") is acting exclusively for the Company and no one else in connection with the equity issue. Collins Stewart does not regard any other person (whether or not a recipient of this announcement) as its client in relation to the equity issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the content of this announcement or any transaction or other matter referred to herein.
Related Shares:
Medicx Fund